BAM Brookfield AM Q4 2025 EPS beats analyst projections by 6 percent shares rise 06 percent on the day TE T1 Energy Q4 2025 soaring revenue growth fails to offset steep EPS miss pulling shares 28 percent lower PBMWW Psyence highlights clinical trial progress as core strategic priority in its latest quarterly earnings release AMREP AXR Stock Is It Worth Buying Q1 2026 Profit Surprises